Back to Search
Start Over
Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study.
- Source :
- PLoS ONE, Vol 14, Iss 1, p e0210593 (2019)
- Publication Year :
- 2019
- Publisher :
- Public Library of Science (PLoS), 2019.
-
Abstract
- [This corrects the article DOI: 10.1371/journal.pone.0164646.].
Details
- Language :
- English
- ISSN :
- 19326203
- Volume :
- 14
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- PLoS ONE
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.84a81f1520c4d6e9e34354e7c569191
- Document Type :
- article
- Full Text :
- https://doi.org/10.1371/journal.pone.0210593